title: Metabolism of a long-chain diacylglycerol by permeabilized A10 smooth muscle cells.
abstract: The regulatory effects of diacylglycerol (DAG) second messengers will be terminated by metabolism. A long-chain DAG, 1-palmitoyl-2-[1-14C]oleoyl-sn-glycerol (2-[14C]POG), was metabolized by cultured A10 smooth muscle cells after permeabilization by preincubation with 340 U/ml alpha-toxin from Staphylococcus aureus. In contrast to results with the cell-permeable DAG analogue, dioctanoyl-glycerol ([3H]diC8), no appreciable 2-[14C]POG degradation could be detected in control A10 cells not treated with alpha-toxin. With permeabilized A10 cells, 2-[14C]POG was mainly converted into lipolytic products of a lipase pathway, monoacylglycerol (MG) and fatty acid (FA); very little radioactivity was incorporated into triacylglycerol (TG) or phospholipid (PL) via reactions catalyzed by either DAG acyltransferase, cholinephosphotransferase, or DAG kinase. Similar results were obtained in experiments with 1-stearoyl-2-[1-14C]arachidonoyl-sn-glycerol. The conversion of 2-[14C]POG into PL and TG was not enhanced by the addition of 1 mM ATP-MgCl2, 1 mM CDP-choline, or 1 mM oleoyl-CoA to the alpha-toxin-treated A10 cells. The formation of FA and MG by permeabilized A10 cells was inhibited by DAG lipase inhibitors, U-57,908 (50 microM) and tetrahydrolipstatin (1-25 nM). The predominant contribution of the lipase pathway to the metabolism of a long-chain DAG, 2-[14C]POG, by alpha-toxin-treated A10 cells is similar to results for the degradation of [3H]diC8 by intact A10 cells.
authors.affiliation: Medical Research Council Signal Transduction Group, Faculty of Medicine, University of Calgary, Alberta, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Chuang
authors.forename: M W
authors.initials: MW
authors.lastname: Lee
authors.forename: D
authors.initials: D
authors.lastname: Zhao
authors.forename: D L
authors.initials: DL
authors.lastname: Severson
mesh_terms: D000818:Animals; D002460:Cell Line; D002463:Cell Membrane Permeability; D003512:Cyclohexanones / Q000494:pharmacology; D004075:Diglycerides / Q000378:metabolism*; D007783:Lactones / Q000494:pharmacology; D008071:Lipoprotein Lipase / Q000037:antagonists & inhibitors; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000378:metabolism*; D000077403:Orlistat
chemical_list: D003512:Cyclohexanones; D004075:Diglycerides; D007783:Lactones; C044295:1,2-dioctanoylglycerol; C083975:1-palmitoyl-2-oleoyl-sn-glycerol; C075809:1-stearoyl-2-arachidonoylglycerol; C036535:1,6-bis(cyclohexyloximinocarbonyl)hexane; D000077403:Orlistat; D008071:Lipoprotein Lipase